Product Information
MINOCYCLINE 75 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.3968 per EA under NDC 13668048301. Its NADAC has been published 483 times since Jul 5, 2017.
FDA first approved this application on Nov 30, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668048301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065062FDA Approved
11/30/2000
TE Code
AB
On Market Since
4/2/2015
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 75 MG CAPSULE has been published 483 times since Jul 5, 2017, and over the history we have for it it has declined 15.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3968 per EA |
|---|---|
| All-time high | $0.5390 (May 16, 2018) |
| All-time low | $0.2639 (Feb 19, 2025) |
| 52-week high | $0.4410 |
| 52-week low | $0.3968 |
| Median price | $0.4066 |
| Average price | $0.4026 |
| Largest weekly change | +31.6% (Mar 20, 2024) |
| Weeks tracked | 483 |
| Tracking since | Jul 5, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Minocycline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINOCYCLINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 75 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $0.3968 per EA (NDC 13668048301), effective Sep 30, 2026.
How has the price of MINOCYCLINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 75 MG CAPSULE has declined 15.4%. It has been tracked across 483 weekly CMS publications since Jul 5, 2017.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 75 MG CAPSULE?
Since Jul 5, 2017, the NADAC for MINOCYCLINE 75 MG CAPSULE has ranged from a low of $0.2639 (Feb 19, 2025) to a high of $0.5390 (May 16, 2018), with a median of $0.4066 per EA.
Are there cheaper alternatives to MINOCYCLINE 75 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MINOCYCLINE 75 MG CAPSULE?
MINOCYCLINE 75 MG CAPSULE (NDC 13668048301) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.